The global pressure relief devices market size was estimated at USD 2.53 billion in 2015 and is expected to reach USD 4.14 billion by 2025, growing at a CAGR of 5.1%. The increasing incidence of pressure ulcer development due to a highly susceptible and rapidly growing aging population is expected to drive the market growth over the years to come.
The geriatric population is more prone to the development of pressure ulcers that are also known as bedsores. The number of people aged 60 and above has been substantially increasing in recent years in most of the regions and it is expected to keep growing over the coming years. This factor will be contributing to the market growth.
U.S. pressure relief devices market, by type, 2014 - 2025 (USD Million)
More than 2.5 million people in the U.S. and 0.7 million people in the UK are affected by pressure ulcers every year. Moreover, the treatments for these ulcers cost more than around USD 9 billion every year in the U.S. These alarming expenses are contributing to the rising demand for bedsore management equipment.
The prevention of these ulcers requires an interdisciplinary approach for its management and well-trained hospital staff. Although some parts of the treatment can be streamlined, specific care has to be given according to the requirements of every patient.
As these ulcers can be prevented with proper management, many campaigns have been launched over recent years for raising awareness. Knowledge of available resources facilitates effortless progression through all levels of care. Some of the campaigns initiated by the government of U.K. include, “Stop the Pressure”, “Zero Pressure”, and “Islandwide Pressure Ulcer Prevention Campaign”.
Low-tech devices are the largest type segment of the global pressure relief devices market. The factors contributing to the segment growth mainly include cost-effectiveness of the low-tech mattresses, easy availability in the market, and therapeutic benefits for the prevention of bedsores.
Amongst the low-tech devices, foam-based mattresses held the majority of share in 2015 due to high usage volume and cost-effectiveness. The gel-based mattresses are projected to be the fastest-growing segment over the forecast period owing to their therapeutic benefits in pressure ulcer management.
The high-tech devices are the fastest-growing type segment, due to technological improvements in device designing. Most of the high-tech devices are powered and are specifically designed for periodic pressure redistribution providing several therapeutic benefits to mobility-impaired patients.
Dynamic air therapy beds held the majority of share in the high-tech devices segment, whereas kinetic beds are expected to be the fastest-growing segment over the coming years. The demand for these devices is expected to rise over the forecast period as they are highly technology-based.
North America was identified as the largest market for pressure relief devices in the year 2015. Nearly 18% of the American population will be aged 65 and more by 2025. The aging patients with chronic illnesses are placing a tremendous burden on the healthcare systems.
Furthermore, according to Centers for Medicare and Medicaid Services (CMS), expenditure on hospital-acquired illnesses in the U.S. has grown at a rate of 7% from the year 2000 to 2013. The pressure sores are ranked fourth in the list of 14 hospital-acquired conditions published by the CMS.
On the other hand, the Asia Pacific region is projected to showcase the fastest growth rate over the forecast period. The rising geriatric population in this region, which is more prone to the development of these sores and increasing disposable income, is expected to drive the growth.
Global pressure relief devices market, by Region, 2015
This market is expected to witness impressive growth over the forecast years. The competition between the companies manufacturing these devices is high, as their demand is increasing. Some of the key players in this industry include ArjoHuntleigh; BSN medical, Inc.; Hill-Rom Holdings, Inc.; PARAMOUNT BED HOLDINGS CO., LTD..; Acelity; Invacare Corporation; and Talley Group Ltd.
Some of the companies are focusing on new product launches as a part of their strategic expansion. The market is marked by partnerships between companies and acquisitions of smaller players. For instance, in 2015, ArjoHuntleigh collaborated with BAM Labs to provide BAM Labs Smart Bed Technology to the acute care market in the U.S.
Attribute |
Details |
Base year for estimation |
2015 |
Actual estimates/Historical data |
2014 - 2015 |
Forecast period |
2016 - 2025 |
Market representation |
Revenue in USD Million and CAGR from 2016 to 2025 |
Regional scope |
North America, Europe, Asia Pacific, Latin America & MEA |
Country scope |
U.S., Canada, UK, Germany, Japan, China, Brazil, South Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global pressure relief devices market on the basis of type, and region:
Type Outlook (Revenue, USD Million; 2014 - 2025)
Low-Tech Devices
Foam-Based Mattress
Gel-Based Mattress
Fiber Filled Mattress
Water/Fluid Filled Mattress
Air Filled Mattress
High-Tech Devices
Dynamic Air Therapy Beds
Kinetic Beds
Regional Outlook (Revenue, USD Million; 2014 - 2025)
North America
The U.S.
Canada
Europe
U.K.
Germany
Asia Pacific
Japan
China
Latin America
Brazil
MEA
South Africa
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.